Ferdinando A. Giannone
Bologna, 40138, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Augustus' solar meridian functioning and the birth of the western leap year.
Journal: Scientific reports
Published: July 13, 2024
The Analysis of Food Intake in Patients with Cirrhosis Waiting for Liver Transplantation: A Neglected Step in the Nutritional Assessment.
Journal: Nutrients
Published: August 26, 2019
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.
Journal: Molecular therapy. Nucleic acids
Published: July 06, 2018
Brivanib in combination with Notch3 silencing shows potent activity in tumour models.
Journal: British journal of cancer
Published: June 12, 2018
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.
Journal: Cell death & disease
Published: June 14, 2017
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells.
Journal: Cytotherapy
Published: December 14, 2016
Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule.
Journal: Scientific reports
Published: August 01, 2016
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
Journal: Oncotarget
Published: March 23, 2016
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 02, 2015
Response to The reduced CO(2+) -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus".
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 09, 2015
Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis.
Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 02, 2015
Last Updated: 09/26/2026